All Porphyromonas gingivalis articles
-
NewsCloves and miswak: Antimicrobial effects of Syzygium aromaticum and Salvadora persica against common pathogens in vitro
Clove essential oil (CEO) derived from Syzygium aromaticum and miswak (Salvadora persica) contains bioactive compounds with antimicrobial properties. This study aimed to evaluate the in vitro antimicrobial efficacy of CEO, miswak, and their combination against key peri-implantitis pathogens.
-
NewsDo oral bacteria from tooth infections worsen diabetes risk?
A new study demonstrates that Porphyromonas gingivalis and its lipopolysaccharide are potent drivers of both periapical bone destruction and systemic metabolic dysfunction, acting through an IL-17–dependent inflammatory pathway.
-
NewsStudy links multiple sclerosis with distinct oral microbiome
Researchers have produced the most comprehensive genetic and metabolic analysis to date of the oral microbiome associated with multiple sclerosis (MS). They found that people with MS have a distinct oral microbiome compared to healthy individuals.
-
NewsHeart rhythm disorder traced to bacterium lurking in our gums
A new study finds that a gum disease bacterium can slip into the bloodstream and infiltrate the heart. There, it drives scar tissue buildup—known as fibrosis—distorting the heart’s architecture, interfering with electrical signals, and raising the risk of atrial fibrillation (AFib).
-
NewsBad breath, bad news: how gum disease could worsen liver conditions
A review discusses the close association of oral health and liver diseases, since oral pathogens and their factors can translocate to liver through the gastrointestinal tract and exacerbate chronic liver conditions in multiple ways, as supported by animal and clinical studies.
-
NewsProtect your teeth with fruit and coconut: antimicrobial effects found in biomass compounds
To find an antibacterial that is easy to use and effective in preventing periodontal disease at all ages, researchers verified the antibacterial effect of seven different compounds against the periodontal pathogenic bacteria, Porphyromonas gingivalis.
-
NewsScientists map role of Porphyromonas gingivalis in chemotherapy resistance
A new paper describes how the bacterium Porphyromonas gingivalis interferes with chemotherapy-induced mitophagy, allowing oral cancer tumors to become resistant to the drug’s effects.
-
NewsMatcha mouthwash inhibits bacteria that causes periodontitis
Matcha, a finely ground green tea powder, may help inhibit the growth of Porphyromonas gingivalis, one of the chief bacterial culprits behind periodontitis.
-
NewsOral bacteria accelerate pancreatic cancer development in mice: research reveals key findings
A new study unveils a significant connection between oral bacteria and pancreatic cancer development in mice and sheds light on a previously recognized link between oral health and pancreatic cancer, one of the deadliest forms of cancer.
-
NewsRapid specific detection of oral pathogens using CRISPR-based diagnostics
A study aiming to develop a low-cost, rapid detection technique for the widescale detection and screening of oral microorganisms suitable for point-of-care settings was presented at the 102nd General Session of the IADR.
-
NewsGargling away the bad bacteria in type 2 diabetes can help to control blood sugar
Researchers have found that gargling with an antiseptic mouthwash can reduce ‘bad’ bacteria in the mouths of people with type 2 diabetes, and may lead to better control of their blood sugar.
-
NewsStudy uncovers how gum disease aggravates COPD
A new study shows how periodontitis, an oral disease, activates immune cells associated with aggravated progression of COPD.
-
NewsOral pathogen increases heart attack damage
Researchers have found that a periodontal pathogen, Porphyromonas gingivalis, inhibits autophagosome–lysosome fusion, and can therefore worsen cardiac remodeling and cause cardiac rupture after myocardial infarction.